340 related articles for article (PubMed ID: 7542776)
1. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display.
Shen R; Su ZZ; Olsson CA; Fisher PB
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6778-82. PubMed ID: 7542776
[TBL] [Abstract][Full Text] [Related]
2. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples.
Sun Y; Lin J; Katz AE; Fisher PB
Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032
[TBL] [Abstract][Full Text] [Related]
3. Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
Su Z; Goldstein NI; Fisher PB
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1764-9. PubMed ID: 9465091
[TBL] [Abstract][Full Text] [Related]
4. Transient reduction of PTI-1 expression by short interfering RNAs inhibits the growth of human prostate cancer cell lines.
Yu L; Wu G; Wang L; Wang H; Zhang G
Tohoku J Exp Med; 2006 Jun; 209(2):141-8. PubMed ID: 16707856
[TBL] [Abstract][Full Text] [Related]
5. Translational infidelity and human cancer: role of the PTI-1 oncogene.
Gopalkrishnan RV; Su ZZ; Goldstein NI; Fisher PB
Int J Biochem Cell Biol; 1999 Jan; 31(1):151-62. PubMed ID: 10216950
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
7. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
8. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family.
Su ZZ; Lin J; Shen R; Fisher PE; Goldstein NI; Fisher PB
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7252-7. PubMed ID: 8692978
[TBL] [Abstract][Full Text] [Related]
9. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection.
Su ZZ; Olsson CA; Zimmer SG; Fisher PB
Anticancer Res; 1992; 12(2):297-304. PubMed ID: 1580547
[TBL] [Abstract][Full Text] [Related]
10. Novel human prostate-specific cDNA: molecular cloning, expression, and immunobiology of the recombinant protein.
Naz RK; Santhanam R; Tyagi N
Biochem Biophys Res Commun; 2002 Oct; 297(5):1075-84. PubMed ID: 12372395
[TBL] [Abstract][Full Text] [Related]
11. Deconstructing PTI-1: PTI-1 is a truncated, but not mutated, form of translation elongatin factor 1A1, eEF1A1.
Mansilla F; Hansen LL; Jakobsen H; Kjeldgaard NO; Clark BF; Knudsen CR
Biochim Biophys Acta; 2005 Feb; 1727(2):116-24. PubMed ID: 15716006
[TBL] [Abstract][Full Text] [Related]
12. Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.
Gonsky R; Knauf JA; Elisei R; Wang JW; Su S; Fagin JA
Nucleic Acids Res; 1997 Oct; 25(19):3823-31. PubMed ID: 9380504
[TBL] [Abstract][Full Text] [Related]
13. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
Tan JM; Tock EP; Chow VT
Mol Pathol; 2003 Apr; 56(2):109-15. PubMed ID: 12665628
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
Jing C; El-Ghany MA; Beesley C; Foster CS; Rudland PS; Smith P; Ke Y
J Natl Cancer Inst; 2002 Apr; 94(7):482-90. PubMed ID: 11929948
[TBL] [Abstract][Full Text] [Related]
16. ZFY gene expression and retention in human prostate adenocarcinoma.
Tricoli JV; Bracken RB
Genes Chromosomes Cancer; 1993 Feb; 6(2):65-72. PubMed ID: 7680890
[TBL] [Abstract][Full Text] [Related]
17. The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.
Tseng-Crank J; Kost T; Goetz A; Hazum S; Roberson KM; Haizlip J; Godinot N; Robertson CN; Saussy D
Br J Pharmacol; 1995 Aug; 115(8):1475-85. PubMed ID: 8564208
[TBL] [Abstract][Full Text] [Related]
18. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
Schleicher RL; Hunter SB; Zhang M; Zheng M; Tan W; Bandea CI; Fallon MT; Bostwick DG; Varma VA
Cancer Res; 1997 Aug; 57(16):3532-6. PubMed ID: 9270025
[TBL] [Abstract][Full Text] [Related]
19. Links between Fer tyrosine kinase expression levels and prostate cell proliferation.
Allard P; Zoubeidi A; Nguyen LT; Tessier S; Tanguay S; Chevrette M; Aprikian A; Chevalier S
Mol Cell Endocrinol; 2000 Jan; 159(1-2):63-77. PubMed ID: 10687853
[TBL] [Abstract][Full Text] [Related]
20. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
